Multi Sample Osmometer Improves Testing Efficiency
|
By LabMedica International staff writers Posted on 03 Aug 2016 |

Image: The OsmoPRO multi-sample osmometer for automated testing (Photo courtesy of Advanced Instruments).
A novel 20-position micro sample osmometer improves laboratory efficiency, productivity, and workflow by reducing sample turn-around time.
The OsmoPRO Multi-Sample Osmometer for automated osmolality testing is designed to analyze a variety of complex aqueous mixtures, including blood, serum, plasma, urine, cell culture media, drug formulations, and biological cell therapies, using a small, 20 μL sample size. Samples can be analyzed one at a time, or batch processed depending on workflow demands. Timesaving features include an intuitive touch screen, automated processing, and the ability to run unattended. The device also uses the freezing point depression method to deliver results in just two minutes.
The OsmoPRO can be used in a variety of laboratory applications including clinical diagnostics, formulation development, bioprocess monitoring and process control, industrial, environmental, and finished product quality control. An integrated barcode scanner provides positive sample identification to reduce transcription errors, with data management and transfer handled via the on-board printer or by exporting the data using an ethernet connection and multiple USB ports. The OsmoPRO multi-sample osmometer, a product of Advanced Instruments (Norwood, MA, USA), will be presented at AACC 2016.
“OsmoPRO incorporates more than 60 years of applied technology and expertise from Advanced Instruments, the industry leader in the field of osmometry,” said Peter Costas, vice president of sales and marketing at Advanced Instruments. “OsmoPRO replaces the Advanced Model 2020 osmometer, which has been an extremely popular and reliable osmometer used in thousands of laboratories worldwide, and represents Advanced Instruments commitment to quality and innovation in the field of osmometry”.
Osmometers are used for measuring the osmotic strength of a solution, colloid, or compound, or determining the molecular weight of unknown compounds and polymers. Several techniques can be used, including vapor pressure depression to determine the concentration of osmotically active particles; determining the osmotic pressure of a solution separated from pure solvent by a semipermeable membrane; and freezing point depression to determine osmotically active compounds in a solution.
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.
Related Links:
Advanced Instruments
American Association for Clinical Chemistry
The OsmoPRO Multi-Sample Osmometer for automated osmolality testing is designed to analyze a variety of complex aqueous mixtures, including blood, serum, plasma, urine, cell culture media, drug formulations, and biological cell therapies, using a small, 20 μL sample size. Samples can be analyzed one at a time, or batch processed depending on workflow demands. Timesaving features include an intuitive touch screen, automated processing, and the ability to run unattended. The device also uses the freezing point depression method to deliver results in just two minutes.
The OsmoPRO can be used in a variety of laboratory applications including clinical diagnostics, formulation development, bioprocess monitoring and process control, industrial, environmental, and finished product quality control. An integrated barcode scanner provides positive sample identification to reduce transcription errors, with data management and transfer handled via the on-board printer or by exporting the data using an ethernet connection and multiple USB ports. The OsmoPRO multi-sample osmometer, a product of Advanced Instruments (Norwood, MA, USA), will be presented at AACC 2016.
“OsmoPRO incorporates more than 60 years of applied technology and expertise from Advanced Instruments, the industry leader in the field of osmometry,” said Peter Costas, vice president of sales and marketing at Advanced Instruments. “OsmoPRO replaces the Advanced Model 2020 osmometer, which has been an extremely popular and reliable osmometer used in thousands of laboratories worldwide, and represents Advanced Instruments commitment to quality and innovation in the field of osmometry”.
Osmometers are used for measuring the osmotic strength of a solution, colloid, or compound, or determining the molecular weight of unknown compounds and polymers. Several techniques can be used, including vapor pressure depression to determine the concentration of osmotically active particles; determining the osmotic pressure of a solution separated from pure solvent by a semipermeable membrane; and freezing point depression to determine osmotically active compounds in a solution.
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions on scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.
Related Links:
Advanced Instruments
American Association for Clinical Chemistry
Latest AACC 2016 News
- Molecular Test Detects Three Arboviruses in Plasma Samples
- Derived Exosomal Protein Biomarkers in Alzheimer’s Disease Diagnosis
- New Biochip Array Developed for ApoE4 Classification
- Cell-Free DNA Identifies Liver Transplant Patients with Acute Rejection
- New Method Tested for Early Diagnosis Pediatric Diabetic Nephropathy
- FDA-Cleared Automated Cell Counter for CSF Launched at AACC 2016
- Semen Analysis Portfolio with Two New Products Featured at AACC 2016
- Automation Solutions for Clinical Diagnostic Equipment Showcased at AACC 2016
- New Tubes Designed for Medium Sample Volumes
- Innovative Information System Optimizes Laboratory Processes
- Innovative eLearning Interface Seamlessly Connects Competency Data
- Cloud-Based Connectivity Platform Advances Decentralized Healthcare
- Adhesives Research to Present Hydrophilic Adhesive Technologies
- Point-of-Care Immunoassay Analyzer on Display at AACC Annual Meeting
- Assay for Determination of 17-OH Progesterone to Be Featured at AACC Annual Meeting
- Fully Automated HbA1c Analyzer Available for Inspection at AACC Annual Meeting
Channels
Clinical Chemistry
view channel
FDA-Approved Test Identifies Low Risk of Large Esophageal Varices in Cirrhosis
Chronic liver disease contributes substantially to mortality, and clinicians routinely screen adults with compensated cirrhosis for varices to prevent bleeding. However, endoscopy is invasive and reso... Read more
Blood Protein Signature Diagnoses Pediatric IBD and Distinguishes Subtypes
Confirming pediatric inflammatory bowel disease (IBD) often requires imaging, endoscopy, and histopathology, prolonging time to diagnosis. Reliable, noninvasive blood tests remain an unmet need in routine... Read moreMolecular Diagnostics
view channel
Blood Test Reveals Hidden Pancreatic Cancer After Treatment
Pancreatic cancer often returns even after chemotherapy and surgery, while microscopic disease can remain difficult to detect during surveillance. Standard imaging and broad-panel liquid biopsy tests may... Read more
Model Predicts Increased ALS Clinic Visits with Expanded Genetic Testing
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that rapidly impairs motor function and shortens survival, creating sustained demand for multidisciplinary care.... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channel
Emergency Department Opt-Out Testing Program Identifies Undiagnosed HIV
Undiagnosed HIV continues to drive avoidable morbidity and transmission, with many people identified only after substantial immune damage has occurred. In England, about one in 20 people living with HIV... Read more
Immune Biomarkers Could Identify Risk of Chronic Critical Illness on ICU Admission
Severe traumatic injury can trigger immune and organ dysfunction that complicates recovery in the intensive care unit. A subset of patients develop chronic critical illness, defined as dependence on intensive... Read moreMicrobiology
view channel
H. pylori Screening Within Colorectal Program Aids Gastric Cancer Prevention
Health systems increasingly rely on economic evidence to guide cancer prevention strategies. For gastric cancer, selecting screening approaches that can integrate with existing programs is a key policy question.... Read more
Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer
Colorectal cancer has been repeatedly linked to alterations in the gut microbiome, yet findings have often varied across small, heterogeneous studies. Reproducibility has been limited by differing sequencing... Read morePathology
view channel
Uncertainty-Aware AI Tool Improves Digital Pathology for Cancer Subtyping
Reliable histologic subtyping guides therapy selection in oncology, yet diagnostic workflows grow more complex as whole-slide imaging and artificial intelligence (AI) expand. A persistent obstacle to clinical... Read more
Study Highlights Biomarker Testing Delays in Lung Cancer Care
Timely biomarker results are critical to match lung cancer patients with targeted therapies or immunotherapies, yet many clinical pathways still delay testing after biopsy. Ordering responsibility, reimbursement... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel









